Loading...
XASX
WFL
Market cap880kUSD
Jul 21, Last price  
0.00AUD
Name

Wellfully Ltd

Chart & Performance

D1W1MN
No data to show
P/E
—
P/S
0.98
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
2m
-42.00%
000119,492750,396468,044800,794601,346519,077673,159806,6911,394,6231,339,4041,650,3901,056,6381,249,360570,552462,9732,599,8521,507,815
Net income
-6m
L-21.24%
721,109-1,234,506-1,433,090-1,396,511-925,519-1,732,579-954,931-897,529-1,411,442-1,331,572-2,205,354-2,299,088-3,555,381-5,536,876-1,698,783-1,710,001-3,572,834-6,397,257-8,068,320-6,354,783
CFO
-2m
L-70.38%
00000000000000-1,427,742-1,876,400-2,676,566-5,201,882-8,249,081-2,443,452

Profile

Wellfully Limited, together with its subsidiaries, focuses on the development and commercialization of Dermaportation and ETP transdermal drug delivery technologies. It operates in two segments, Dermaportation Drug Delivery Technology and Devices. The company is also involved in the industrialization and supply-chain support for its existing product ranges; and sale and marketing of its own brands REDUIT and SWISSWELL, as well as third-party collaborations. It serves the pharmaceutical, cosmetic and skincare, and consumer healthcare sectors. The company was formerly known as OBJ Limited and changed its name to Wellfully Limited in September 2020. Wellfully Limited was incorporated in 1992 and is based in Leederville, Australia.
URL
https://www.obj.com.au/
IPO date
May 29, 2000
Employees
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑062015‑06
Income
Revenues
1,508
-42.00%
2,600
461.56%
Cost of revenue
5,163
8,173
Unusual Expense (Income)
NOPBT
(3,656)
(5,573)
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
(3,656)
(5,573)
Net income
(6,355)
-21.24%
(8,068)
26.12%
Dividends
Dividend yield
Proceeds from repurchase of equity
3,152
5,826
BB yield
-283.21%
-46.88%
Debt
Debt current
224
261
Long-term debt
221
434
Deferred revenue
Other long-term liabilities
(46)
Net debt
175
377
Cash flow
Cash from operating activities
(2,443)
(8,249)
CAPEX
(107)
(32)
Cash from investing activities
(107)
(32)
Cash from financing activities
2,991
5,656
FCF
(1,628)
(5,795)
Balance
Cash
270
318
Long term investments
Excess cash
194
188
Stockholders' equity
(1,710)
(146)
Invested Capital
312
1,151
ROIC
ROCE
261.40%
EV
Common stock shares outstanding
371,021
238,999
Price
0.00
-94.23%
0.05
4.00%
Market cap
1,113
-91.04%
12,428
59.19%
EV
1,288
12,805
EBITDA
(3,542)
(5,401)
EV/EBITDA
Interest
56
Interest/NOPBT